Trial NCT03161041

View at ClinicalTrials.gov 
Org. Study IDs: 69HCL17_0239

Last trial update was posted on 2018-11-14

MeSH Interventions

Bevacizumab Oxaliplatin

MeSH Conditions

Carcinoma

Other Conditions

Colorectal Carcinomatosis

Stopping Reasons

CHU Lyon will join as a participating center (and as national French coordinator) as a part of the BEV-IP study ongoing study EudraCT-number 2014-004257-14.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID